Advertisement

Pharmaceutical Technology is using cookies

We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.

ContinueLearn More X
X
Analysis

US opioid crisis: charting Insys’ fall from grace

Insys, the owner of potent opioid Subsys, has become the first pharma industry casualty of the US opioid crisis, which caused more than 70,000 overdose deaths in 2017 alone. What series of events led to its multi-million dollar settlement and declaration of bankruptcy in May this year?

Close
Close
Close

Go Top